The journal of mental health administration

, Volume 18, Issue 1, pp 21–26 | Cite as

Early HIV detection: A community mental health role

  • Michael D. Knox
  • Charles F. Clark
Regular Articles


This paper documents the changing need for early detection of human immunodeficiency virus (HIV) infection and proposes a role for community mental health centers (CMHCs). Ignorance of HIV infection status can result in greater risk of medical complications and denies the individual the opportunity to take the steps necessary to prolong life and prevent further transmission of the virus Individuals who know they are infected can obtain good medical care, avoid infection, avoid becoming pregnant, behave responsibly and plan their lives appropriately. Advances in specific therapeutics now make it important for infected individuals to know their HIV status well before becoming overtly ill. The social history, sexual history, drug use history, and physical and mental status of each client will provide important clues regarding infection status. Reluctance to refer for testing because of concerns about level of stress. liability and confidentiality should be tempered by a policy of referring for testing whenever any indication of infection arises.


Human Immunodeficiency Virus Human Immunodeficiency Virus Type Human Immunodeficiency Virus Infection Community Mental Health Community Mental Health Center 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Dow MG, Knox MD, Cotton DA: Administrative challenges to working with HIV-positive clients: experiences of mental health and substance abuse program directors in Florida. The Journal of Mental Health Administration 1989; 16:80–90.Google Scholar
  2. 2.
    Dow MG, Knox MD: Attitudes and Knowledge About AIDS and Administrative Impediments to Service in Florida’s State-Funded Community Mental Health Centers and Drug Abuse Treatment Programs. Tampa: Florida Mental Health Institute, 1988.Google Scholar
  3. 3.
    Knox MD, Dow MG, Cotton DA: Mental health care providers: the need for AIDS education. AIDS Education and Prevention 1989; 1:285–290.PubMedGoogle Scholar
  4. 4.
    Knox MD: HIV Spectrum Clients and Community Mental Health. Paper presented at the World Congress For Mental Health. Auckland, New Zealand, 1989.Google Scholar
  5. 5.
    Blendon RJ, Donelan K: Discrimination against people with AIDS. New England Journal of Medicine 1988; 319:1022–1026.PubMedCrossRefGoogle Scholar
  6. 6.
    Moss AR, Bacchetti P: Natural history of HIV infection. AIDS 1989; 3:55–61.CrossRefPubMedGoogle Scholar
  7. 7.
    Redfield RR, Burke DS: HIV infection: the clinical picture. Scientific American 1988; 259:90–98.PubMedCrossRefGoogle Scholar
  8. 8.
    Glasser R, Kiecolt-Glasser J: Stress associated immune suppression and acquired immune deficiency syndrome (AIDS) review. Advances in Biochemical Psychopharmacology 1988; 44:203–215.Google Scholar
  9. 9.
    Redfield RR, Wright DC, James WD, et al: Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. New England Journal of Medicine 1989; 316:673–676.CrossRefGoogle Scholar
  10. 10.
    Mosca JD, Bednarik, Raj NBK, et al: Herpes simplex virus type-1 can reactivate transcription of latent human immunodeficiency virus. Nature 1987; 325:67–70.CrossRefPubMedGoogle Scholar
  11. 11.
    Tramont EC. Syphilis in the AIDS era. New England Journal Medicine 1987; 316:1600–1601.CrossRefGoogle Scholar
  12. 12.
    Iseman MD: Is standard chemotherapy adequate in tuberculosis patients infected with the HIV? American Review of Respiratory Diseases 1987; 136:1326.Google Scholar
  13. 13.
    Lazizi Y, Grangeot-Keros L, Delfraissy JD, et al: Reappearance of hepatitis B virus in immune patients infected with the human immunodeficiency virus type 1 Journal of Infectious Diseases 1988; 158:666–667.PubMedGoogle Scholar
  14. 14.
    Measles in HIV-infected children Morbidity and Mortality Weekly Report 1988; 259:2352–2357.Google Scholar
  15. 15.
    Fischl MA, Richman DD, Grieco MH, et al: The efficacy of azido thymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind, placebo-controlled trial. New England Journal of Medicine 1987; 317:185–191.PubMedCrossRefGoogle Scholar
  16. 16.
    Nightingale SL: Dideoxyinosine available under treatment IND and open safety protocal. Journal of the American Medical Association 1989; 262:2503.CrossRefPubMedGoogle Scholar
  17. 17.
    Yarchoan R, Mitsuya H, Myers CE, et al: Clinical pharmacology of 3′ azido-2′, 3′-dideoxythymidine (zidovudine) and related dideoxynucleosides. New England Journal of Medicine 1989; 321:726–738.PubMedCrossRefGoogle Scholar
  18. 18.
    Glatt AE, Chirgwin K, Landesman SH: Treatment of infections associated with human immunodeficiency virus. New England Journal of Medicine 1988; 318:1439–1446.PubMedCrossRefGoogle Scholar
  19. 19.
    Bigger RJ, Pahwa S, Minkoff H, et al: Immunosuppression in pregnant women infected with human immunodeficiency virus. American Journal of Obstretrics and Gynecology 1989; 161:1239–1244.Google Scholar
  20. 20.
    Blanche S, Rouzious C, Moscato ML, et al: A prospective study of infants born to women seropositive for human immunodeficiency virus type 1: HIV infection in newborns french collaborative study group. New England Journal of Medicine 1989; 320:1643–1648.PubMedCrossRefGoogle Scholar
  21. 21.
    Scott GB, Hutto C, Makuch RW, et al: Survival in children with perinatally acquired human immunodeficiency virus type 1 infection. New England Journal of Medicine 1989; 321:1791–1796.PubMedCrossRefGoogle Scholar
  22. 22.
    Wenger JD, Whalen CC, Lederman MM, et al: Prognostic factors in acquired immunodeficiency syndrome. Journal of General Internal Medicine 1988; 3:464–470.PubMedGoogle Scholar
  23. 23.
    Horwath E, Kramer M, Cournos F, et al: Clinical presentations of AIDS and HIV infection in state psychiatric facilities. Hospital and Community Psychiatry 1989; 40:502–506.PubMedGoogle Scholar
  24. 24.
    Cournos F, Empfield M, Horwath E, et al: The management of HIV infection in state psychiatric hospitals. Hospital and Community Psychiatry 1989; 40:153–157.PubMedGoogle Scholar
  25. 25.
    Knox MD: Community mental health’s role in the AIDS crisis. Community Mental Health Journal 1989; 25:185–196.CrossRefPubMedGoogle Scholar
  26. 26.
    Centers for Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Morbidity and Mortality Weekly Report 1987; 36(1S): 3S-15S.Google Scholar
  27. 27.
    Centers for Disease Control: Update: acquired immunodeficiency syndrome-United States, 1981–1988. Morbidity and Mortality Weekly Report 1989; 38:229–236.Google Scholar
  28. 28.
    Navia BA, Jordan BD, Price RW: The AIDS dementia complex I: clinical features. Annals of Neurology 1986; 19:517–524.CrossRefPubMedGoogle Scholar
  29. 29.
    Detmer WM, Lu FG: Neuropsychiatric complications of AIDS: a literature review. International Journal of Psychiatry in Medicine 1986-87; 16:21–29.PubMedCrossRefGoogle Scholar
  30. 30.
    Bridge TP: AIDS and HIV CNS disease: a neuropsychiatric disorder. Advances in Biochemical Psychopharmacology 1988;44:1–13.PubMedGoogle Scholar
  31. 31.
    Portegies P, de Gans J, Lange JMA, et al: Declining incidence of AIDS dementia complex after introduction of zidovudine treatment. British Medical Journal 1989; 299:819–821.PubMedCrossRefGoogle Scholar
  32. 32.
    Yarchoan R, Berg G, Brouwers P, et al: Response of the human immunodeficiency-virus-associated neurological disease to 3′-azido-3′ deoxythymidine. Lancet 1987; 1:132–135.CrossRefPubMedGoogle Scholar
  33. 33.
    Schmitt FA, Bigley JW, McKinnis R, et al: Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDs and AIDS-related complex. New England Journal of Medicine 1988; 319:1573–1578.PubMedCrossRefGoogle Scholar
  34. 34.
    Centers for Disease Control: AIDS and human immunodeficiency virus infection in the United States: 1988 update. Morbidity and Mortality Weekly Report 1989; 38(S-4):1–14.Google Scholar
  35. 35.
    Centers for Disease Control: Update: heterosexual transmission of acquired immunodeficiency syndrome and human immunodeficiency virus infection. Morbidity and Mortality Weekly Report 1989; 38:423–434.Google Scholar
  36. 36.
    Goldsmith MA: Sex tied to drugs=STD spread. Journal of the American Medical Association 1988; 260:2009.CrossRefPubMedGoogle Scholar
  37. 37.
    Clumeck N, Taelman H, Hermans P, et al: A cluster of HIV infection among heterosexual people without apparent risk factors. New England Journal of Medicine 1989; 321:1460–1462.PubMedCrossRefGoogle Scholar

Copyright information

© Association of Mental Health Administrators 1991

Authors and Affiliations

  • Michael D. Knox
    • 1
    • 2
  • Charles F. Clark
    • 2
    • 3
  1. 1.Department of Community Mental Health, Florida Mental Health InstituteTampaUSA
  2. 2.University of South florida Center for HIV Education and ResearchUSA
  3. 3.Department of Psychiatry and Behavioral Medicine, College of MedicineUniversity of South FloridaUSA

Personalised recommendations